These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30059757)

  • 1. Echolucency-based phenotype in carotid atherosclerosis disease for risk stratification of diabetes patients.
    Kotsis V; Jamthikar AD; Araki T; Gupta D; Laird JR; Giannopoulos AA; Saba L; Suri HS; Mavrogeni S; Kitas GD; Viskovic K; Khanna NN; Gupta A; Nicolaides A; Suri JS
    Diabetes Res Clin Pract; 2018 Sep; 143():322-331. PubMed ID: 30059757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic TPA (mTPA) and composite risk score for moderate carotid atherosclerotic plaque is strongly associated with HbA1c in diabetes cohort.
    Cuadrado-Godia E; Maniruzzaman M; Araki T; Puvvula A; Jahanur Rahman M; Saba L; Suri HS; Gupta A; Banchhor SK; Teji JS; Omerzu T; Khanna NN; Laird JR; Nicolaides A; Mavrogeni S; Kitas GD; Suri JS;
    Comput Biol Med; 2018 Oct; 101():128-145. PubMed ID: 30138774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear model for the carotid artery disease 10-year risk prediction by fusing conventional cardiovascular factors to carotid ultrasound image phenotypes: A Japanese diabetes cohort study.
    Khanna NN; Jamthikar AD; Araki T; Gupta D; Piga M; Saba L; Carcassi C; Nicolaides A; Laird JR; Suri HS; Gupta A; Mavrogeni S; Kitas GD; Suri JS
    Echocardiography; 2019 Feb; 36(2):345-361. PubMed ID: 30623485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
    Lind L; Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
    J Am Soc Echocardiogr; 2012 Oct; 25(10):1120-1127.e1. PubMed ID: 22884641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of carotid atherosclerosis, intraplaque neovascularization, and plaque ulceration using quantitative contrast-enhanced ultrasound in asymptomatic patients with diabetes mellitus.
    van den Oord SC; Akkus Z; Renaud G; Bosch JG; van der Steen AF; Sijbrands EJ; Schinkel AF
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1213-8. PubMed ID: 24972806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of ultrasonic tissue characterization of carotid plaque in the prediction of cardiovascular events in diabetic patients.
    Irie Y; Katakami N; Kaneto H; Takahara M; Nishio M; Kasami R; Sakamoto K; Umayahara Y; Sumitsuji S; Ueda Y; Kosugi K; Shimomura I
    Atherosclerosis; 2013 Oct; 230(2):399-405. PubMed ID: 24075774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral embolism during carotid artery stenting: role of carotid plaque echolucency.
    Rosenkranz M; Wittkugel O; Waiblinger C; Thomalla G; Krutzelmann A; Havemeister S; Zeumer H; Gerloff C; Fiehler J
    Cerebrovasc Dis; 2009; 27(5):443-9. PubMed ID: 19295207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of carotid plaque echolucency in addition to plaque size increases the predictive value of carotid ultrasound for coronary events in patients with coronary artery disease and mild carotid atherosclerosis.
    Hirano M; Nakamura T; Kitta Y; Sano K; Kodama Y; Kobayashi T; Fujioka D; Saito Y; Yano T; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
    Atherosclerosis; 2010 Aug; 211(2):451-5. PubMed ID: 20362290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for IVUS-based coronary artery disease risk stratification: A link between coronary & carotid ultrasound plaque burdens.
    Araki T; Ikeda N; Shukla D; Londhe ND; Shrivastava VK; Banchhor SK; Saba L; Nicolaides A; Shafique S; Laird JR; Suri JS
    Comput Methods Programs Biomed; 2016 Feb; 124():161-79. PubMed ID: 26707374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke Risk Stratification and its Validation using Ultrasonic Echolucent Carotid Wall Plaque Morphology: A Machine Learning Paradigm.
    Araki T; Jain PK; Suri HS; Londhe ND; Ikeda N; El-Baz A; Shrivastava VK; Saba L; Nicolaides A; Shafique S; Laird JR; Gupta A; Suri JS
    Comput Biol Med; 2017 Jan; 80():77-96. PubMed ID: 27915126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carotid plaque echogenicity based on the integral of the cumulative probability distribution using gray-scale ultrasound images.
    Huang X; Zhang Y; Meng L; Abbott D; Qian M; Wong KKL; Zheng R; Zheng H; Niu L
    PLoS One; 2017; 12(10):e0185261. PubMed ID: 28977008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased echolucency of carotid plaques in patients with type 2 diabetes.
    Ostling G; Hedblad B; Berglund G; Gonçalves I
    Stroke; 2007 Jul; 38(7):2074-8. PubMed ID: 17525393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echolucency of carotid plaques correlates with plaque cellularity.
    Gonçalves I; Moses J; Pedro LM; Dias N; Fernandes e Fernandes J; Nilsson J; Ares MP
    Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):32-8. PubMed ID: 12819645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study.
    Peters SA; Lind L; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen J; Bots ML; den Ruijter HM;
    J Intern Med; 2012 Sep; 272(3):257-66. PubMed ID: 22172243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-mode ultrasonographic characterization of carotid atherosclerotic plaques in symptomatic and asymptomatic patients.
    Grogan JK; Shaalan WE; Cheng H; Gewertz B; Desai T; Schwarze G; Glagov S; Lozanski L; Griffin A; Castilla M; Bassiouny HS
    J Vasc Surg; 2005 Sep; 42(3):435-41. PubMed ID: 16171584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease.
    Sirico G; Brevetti G; Lanero S; Laurenzano E; Luciano R; Chiariello M
    J Vasc Surg; 2009 Feb; 49(2):346-51. PubMed ID: 19028065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients.
    Reiter M; Effenberger I; Sabeti S; Mlekusch W; Schlager O; Dick P; Puchner S; Amighi J; Bucek RA; Minar E; Schillinger M
    Radiology; 2008 Sep; 248(3):1050-5. PubMed ID: 18710994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echogenicity of medium-to-large carotid plaques predicts future vascular events.
    Tadokoro Y; Sakaguchi M; Yamagami H; Okazaki S; Furukado S; Matsumoto M; Miwa K; Yagita Y; Mochizuki H; Kitagawa K
    Cerebrovasc Dis; 2014; 38(5):354-61. PubMed ID: 25427642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study.
    Johnsen SH; Mathiesen EB; Joakimsen O; Stensland E; Wilsgaard T; Løchen ML; Njølstad I; Arnesen E
    Stroke; 2007 Nov; 38(11):2873-80. PubMed ID: 17901390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.